Interferon therapy in chronic hepatitis C virus in the prevention of worsening independently of ALT response: Is it conceivable?

Hepato-Gastroenterology

Volumn 48, Issue 41, 2001, Pages

  Testino, G ^a   Ansaldi, F ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; LIVER CIRRHOSIS; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RELAPSE; SEROTYPE; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0034781677     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. r-Interferon alfa-2b/Ribavirin combined therapy followed by low-dose r-Interferon alfa-2b in chronic hepatitis C Interferon non responders
2. Retrospective analysis of the effect of Interferon therapy on the clinical outcome of patients with viral cirrhosis
3. A randomized, controlled trial of maintenance Interferon therapy for patients with chronic hepatitis C virus and persistent viremia